Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      CVS rolls out new tool to combat rising drug prices

      CVS rolls out new tool to combat rising drug prices

      Ruby Khatun Khatun13 April 2018 9:45 AM IST
      Drugstore chain CVS Health Corp launched a new tool that will allow pharmacies help customers tackle the soaring cost of drugs by comparing prices of...
      Johnson and Johnson, Imerys unit must pay 117 million dollars in asbestos cancer case

      Johnson and Johnson, Imerys unit must pay 117 million dollars in asbestos cancer case

      Ruby Khatun Khatun13 April 2018 9:30 AM IST
      New York: Johnson and Johnson and Imerys Talc America, a unit of Imerys SA, must pay $117 million in damages in a case involving a man who said he...
      IHH proposes 1.3 billion dollar bid for Fortis: Report

      IHH proposes 1.3 billion dollar bid for Fortis: Report

      Ruby Khatun Khatun12 April 2018 3:37 PM IST
      IHH Healthcare Berhad has proposed a potential bid of as much as $1.3 billion for Fortis Healthcare Ltd. that tops an offer from a TPG-backed...
      Credit rating agency downgrades Fortis

      Credit rating agency downgrades Fortis

      Ruby Khatun Khatun12 April 2018 11:18 AM IST
      New Delhi: Rating agency ICRA has downgraded Fortis Healthcare and its subsidiaries Escorts Heart Institute and Research Centre, Fortis Hospitals and...
      Milan Paleja to head Novartis operations in India

      Milan Paleja to head Novartis operations in India

      Ruby Khatun Khatun12 April 2018 10:30 AM IST
      New Delhi: Drug firm Novartis India said it has appointed Milan Paleja as Country President with immediate effect.Paleja, who succeeds Jawed Zia, will...
      FDA clears first contact lens with light-adaptive technology

      FDA clears first contact lens with light-adaptive technology

      Ruby Khatun Khatun12 April 2018 10:00 AM IST
      The U.S. Food and Drug Administration (FDA) cleared the first contact lens to incorporate an additive that automatically darkens the lens when exposed...
      New GSK shingles vaccine off to strong start in key US market

      New GSK shingles vaccine off to strong start in key US market

      Ruby Khatun Khatun12 April 2018 9:45 AM IST
      LONDON: GlaxoSmithKline's (GSK) new shingles vaccine - a priority product as the company strives to improve its drugs line-up - has won more than 90...
      FDA needs more time to review AbbVie, Neurocrines uterine pain drug

      FDA needs more time to review AbbVie, Neurocrine's uterine pain drug

      Ruby Khatun Khatun12 April 2018 9:30 AM IST
      AbbVie Inc and Neurocrine Biosciences Inc said the U.S. Food and Drug Administration (FDA) notified the companies that it requires more time to review...
      Bring Cataract Lenses, Syringes, IV Fluid Sets, Urine Bags under Price Ceiling: Maha Govt tells Health Ministry

      Bring Cataract Lenses, Syringes, IV Fluid Sets, Urine Bags under Price Ceiling: Maha Govt tells Health Ministry

      Ruby Khatun Khatun11 April 2018 4:10 PM IST
      Mumbai: The Maharashtra government has submitted a report to the Union Health Ministry, seeking the addition of 18 medical tools or equipments in the...
      Dr Reddys gets EIR from USFDA for Cuernavaca plant in Mexico

      Dr Reddy's gets EIR from USFDA for Cuernavaca plant in Mexico

      Ruby Khatun Khatun11 April 2018 10:15 AM IST
      New Delhi: Drug firm Dr Reddy's Laboratories said it has received establishment inspection report from the US health regulator for its Cuernavaca...
      Mylan to buy MS drug marketing rights from Mapi Pharma

      Mylan to buy MS drug marketing rights from Mapi Pharma

      Ruby Khatun Khatun11 April 2018 9:45 AM IST
      Mylan NV will buy global marketing rights to an experimental multiple sclerosis treatment from Israel’s Mapi Pharma, aiming to strengthen its position...
      Manipal Health raises offer for Fortis Healthcare- Firm now valued at Rs 6,061 crore

      Manipal Health raises offer for Fortis Healthcare- Firm now valued at Rs 6,061 crore

      Ruby Khatun Khatun11 April 2018 9:44 AM IST
      New Delhi: Manipal Health Enterprises raised its offer for Fortis Healthcare Ltd by valuing the hospital business higher at Rs 6,061 crore, according...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok